Green Darci, Duque Gustavo, Fredman Nick, Rizvi Aoun, Brennan-Olsen Sharon Lee
Australian Institute for Musculoskeletal Science (AIMSS), University of Melbourne, Melbourne, Victoria, Australia.
Department of Medicine-Western Health, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia.
BMJ Open. 2018 Jan 13;8(1):e019088. doi: 10.1136/bmjopen-2017-019088.
INTRODUCTION: Sarcopenia (or loss of muscle mass and function) is a relatively new area within the field of musculoskeletal research and medicine. Investigating whether there is a social gradient, including occupation type and income level, of sarcopenia, as observed for other diseases, will contribute significantly to the limited evidence base for this disease. This new information may inform the prevention and management of sarcopenia and widen the evidence base to support existing and future health campaigns. METHODS AND ANALYSIS: We will conduct a systematic search of the databases PubMed, Ovid, CINAHL, Scopus and EMBASE to identify articles that investigate associations between social determinants of health and sarcopenia in adults aged 50 years and older. Eligibility of the selected studies will be determined by two independent reviewers. The methodological quality of eligible studies will be assessed according to predetermined criteria. Established statistical methods to identify and control for heterogeneity will be used, and where appropriate, we will conduct a meta-analysis. In the event that heterogeneity prevents numerical synthesis, a best evidence analysis will be employed. This systematic review protocol adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols reporting guidelines and will be registered with the International Prospective Register of Systematic Reviews (PROSPERO). ETHICS AND DISSEMINATION: This systematic review will use published data, thus ethical permissions will not be required. In addition to peer-reviewed publication, our results will be presented at (inter)national conferences relevant to the field of sarcopenia, ageing and/or musculoskeletal health and disseminated both electronically and in print. PROSPERO REGISTRATION NUMBER: CRD42017072253.
引言:肌肉减少症(即肌肉质量和功能的丧失)是肌肉骨骼研究与医学领域中一个相对较新的领域。像对其他疾病的观察那样,探究肌肉减少症是否存在包括职业类型和收入水平在内的社会梯度,将极大地有助于为这种疾病扩充有限的证据基础。这些新信息可能为肌肉减少症的预防和管理提供依据,并拓宽证据基础以支持现有的及未来的健康宣传活动。 方法与分析:我们将对PubMed、Ovid、CINAHL、Scopus和EMBASE数据库进行系统检索,以识别调查50岁及以上成年人健康的社会决定因素与肌肉减少症之间关联的文章。选定研究的合格性将由两名独立评审员确定。符合条件的研究的方法学质量将根据预定标准进行评估。将使用既定的统计方法来识别和控制异质性,并且在适当时,我们将进行荟萃分析。如果异质性妨碍数值合成,将采用最佳证据分析。本系统评价方案遵循系统评价与荟萃分析方案的首选报告项目报告指南,并将在国际前瞻性系统评价注册库(PROSPERO)中注册。 伦理与传播:本系统评价将使用已发表的数据,因此无需伦理许可。除了同行评审发表外,我们的结果将在与肌肉减少症、衰老和/或肌肉骨骼健康领域相关的(国际)会议上展示,并以电子和印刷形式传播。 PROSPERO注册号:CRD42017072253。
Cochrane Database Syst Rev. 2022-2-1
Early Hum Dev. 2020-11
Int J Environ Res Public Health. 2020-4-21
Gerontol Geriatr Med. 2017-6-14
Calcif Tissue Int. 2017-4-18
J Cachexia Sarcopenia Muscle. 2016-10-17